KMPR

Kemper is a specialty P&C insurer two years into a recovery. After three straight loss years (net income of -$124M, -$287M and -$272M across FY2021-2023), it swung to a $318M profit in FY2024, and FY2025 net income of $143M — though down 54.9% YoY — keeps it in the black while revenue finally turned up (+3.3% to $4.79B) after a multi-year slide from $5.72B. Operating cash flow of $585M (+52.7%) and the resumed buyback ($302M, shrinking the share count 8.1%) show real capital generation, and at $27.31 the stock trades at roughly 0.60x book (equity $2.68B / 58.7M shares = ~$45.66/share). For an insurer earning a 5.3% ROE, a sub-book valuation is rational rather than a gift — the market is pricing returns below the cost of equity. Buying back stock well under book is the right, value-accretive use of that cash.

The quality case is mixed. The 11.9x P/E sits on an EPS ($2.29) that itself fell 53.4%, so the trailing multiple flatters a year of declining earnings; the swing from a ~$4.91 prior-year EPS to $2.29 underlines how volatile underwriting results remain. Leverage is typical-to-elevated for the sector at 3.66x liabilities/equity, and the holding-company cash balance is thin at $126M. The MD&A discloses a restructuring program launched Q3 2025 targeting efficiencies through 2027 and a pending full exit of the non-core Preferred Insurance business — both should de-risk the cost base if executed.